Gero
About:
Gero is a biotechnology company that provides therapeutics against chronic diseases.
Website: https://www.gero.ai
Twitter/X: hacking_aging
Top Investors: VitaDAO, Bulba Ventures, Melnichek Investments, Leo Lozner
Description:
GERO is an AI Drug Discovery company created to solve chronic diseases
Total Funding Amount:
$6M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Singapore, Central Region, Singapore
Founded Date:
2018-01-01
Contact Email:
info(AT)gero.ai
Founders:
Maxim Kholin, Peter Fedichev, Place holder Place holder
Number of Employees:
11-50
Last Funding Date:
2023-10-18
IPO Status:
Private
Industries:
© 2025 bioDAO.ai